The first core area involved improving the medical center's culture and systems for using unique patient identifiers and wristbands. In 2003, the medical center launched initiatives to identify ...
We convened interdisciplinary teams and conducted failure mode and effects analyses (FMEAs) for five oral chemotherapy agents: capecitabine, imatinib, temozolomide, 6-mercaptopurine, and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results